{"organizations": [], "uuid": "5fdd9a8f7b2934519d149e124c970970960c1a0a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/drugmaker-takeda-shares-tumble-as-company-considers-bid-for-shire-idUST9N1QR00D", "country": "US", "domain_rank": 408, "title": "Drugmaker Takeda shares tumble as company considers bid for Shire", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T08:16:00.000+03:00", "replies_count": 0, "uuid": "5fdd9a8f7b2934519d149e124c970970960c1a0a"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/drugmaker-takeda-shares-tumble-as-company-considers-bid-for-shire-idUST9N1QR00D", "ord_in_thread": 0, "title": "Drugmaker Takeda shares tumble as company considers bid for Shire", "locations": [], "entities": {"persons": [{"name": "minami funakoshi", "sentiment": "none"}, {"name": "takeda", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "chang-ran kim", "sentiment": "none"}], "locations": [{"name": "shire tokyo", "sentiment": "none"}, {"name": "tokyo", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "takeda pharmaceutical", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "shire", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "TOKYO, March 29 (Reuters) - Takeda Pharmaceutical shares sank 5 percent early on Thursday, a day after Japan’s largest drugmaker said it was considering a bid for London-listed rare disease specialist Shire that could top $40 billion.\nShares in Takeda fell more than 5 percent in early morning trade, sharply underperforming the broader Tokyo market, which was slightly higher.\nTakeda said on Wednesday it was “at a preliminary and exploratory stage” of considering a bid that could spark another takeover battle in the deal-hungry pharma industry. Shire’s shares ended 15.7 percent higher, valuing the group at around 32 billion pounds ($45 billion). (Reporting by Minami Funakoshi Editing by Chang-Ran Kim)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-29T08:16:00.000+03:00", "crawled": "2018-03-29T16:10:06.068+03:00", "highlightTitle": ""}